ArticleOncotarget2015

ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.

Katherine E Hutchinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.